[1]
“Zidovudine/Lamivudine vs. Abacavir/Lamivudine vs. Tenofovir/Emtricitabine in fixed-dose combinations as initial treatment for HIV patients: a systematic review and network meta-analysis”, Colomb Med, vol. 48, no. 2, pp. 70–81, Jun. 2017, doi: 10.25100/cm.v48i2.2774.